2m 2m 2m 2m 2m 2m 2m
Metagenomi Thera (MGX)
NASDAQ
$1.34+$0.005 (+0.38%)
Price as of Jun 03, 2026 4:10 PM EDT- $51.2MMarket Cap
- -24.86%1-Year Change
- BiotechnologyIndustry
Metagenomi Thera (MGX)
$1.34+$0.005 (+0.38%)
MGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.33 | ||
Change | +$0.02 (+1.53%) | ||
Open | $1.30 | ||
High | $1.36 | ||
Low | $1.29 | ||
Previous Close | $1.31 | ||
Volume | 203,130 | ||
30-Day Average Volume | 192,066 | ||
1-Week Change | -2.21% | ||
1-Month Change | -4.32% | ||
1-Year Change | -24.86% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.6M | ||
Total Assets | $197.0M | ||
Market Cap | $51.2M | ||
Enterprise Value | $25.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$23.1M | ||
Free Cash Flow | -$21.2M | ||
EBIT | -$23.0M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $122.1M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | 2 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue